TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 326 filers reported holding TANDEM DIABETES CARE INC in Q3 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $846,294 | +45.2% | 40,746 | +71.6% | 0.29% | +55.4% |
Q2 2023 | $582,727 | -39.6% | 23,746 | 0.0% | 0.19% | -40.2% |
Q1 2023 | $964,325 | -54.6% | 23,746 | -49.7% | 0.31% | -48.3% |
Q4 2022 | $2,124,022 | +1.4% | 47,253 | +8.0% | 0.60% | +0.5% |
Q3 2022 | $2,094,000 | -19.2% | 43,753 | 0.0% | 0.60% | -16.6% |
Q2 2022 | $2,590,000 | -54.3% | 43,753 | -10.3% | 0.72% | -32.9% |
Q1 2022 | $5,669,000 | -28.2% | 48,753 | -7.0% | 1.07% | -23.8% |
Q4 2021 | $7,892,000 | +18.1% | 52,429 | -6.4% | 1.40% | +46.7% |
Q3 2021 | $6,683,000 | +5.6% | 55,985 | -13.8% | 0.96% | +9.5% |
Q2 2021 | $6,330,000 | +10.4% | 64,985 | 0.0% | 0.87% | +5.8% |
Q1 2021 | $5,735,000 | +313.5% | 64,985 | +348.2% | 0.82% | +255.6% |
Q4 2020 | $1,387,000 | -15.7% | 14,500 | 0.0% | 0.23% | -24.7% |
Q3 2020 | $1,646,000 | +14.8% | 14,500 | 0.0% | 0.31% | +26.7% |
Q2 2020 | $1,434,000 | +134.7% | 14,500 | +52.6% | 0.24% | +107.7% |
Q1 2020 | $611,000 | – | 9,500 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |